NCT01703754Phase 2Terminated

Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.

Study sponsor: Alaunos Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2014-08-07Actual
Enrollment · participants12Actual
Source updated2025-08-28Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview